Activation of PDGFR‐β was sufficient to drive progressive renal fibrosis, and this created a unique model allowing to specifically study the consequences, reversibility, and therapeutic interventions of renal fibrosis independent of inflammation, hypertension, or epithelial or endothelial injury. This evidence concerns the gene PDGFRB and renal fibrosis.